Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹181Cr
Rev Gr TTM
Revenue Growth TTM
33.65%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ZEAL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -37.5 | 82.2 | -6.4 | 1.9 | -0.5 | 9.1 | 30.7 | 24.2 | 57.7 | 42.0 | 21.4 | 31.1 |
| 61 | 77 | 112 | 130 | 57 | 82 | 146 | 157 | 92 | 117 | 174 | 213 |
Operating Profit Operating ProfitCr |
| 6.3 | 4.2 | 3.6 | 4.4 | 11.6 | 5.7 | 3.7 | 7.0 | 10.2 | 5.3 | 5.6 | 4.1 |
Other Income Other IncomeCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 2 | 1 | 8 |
Interest Expense Interest ExpenseCr | 3 | 3 | 4 | 3 | 4 | 4 | 5 | 8 | 5 | 5 | 6 | 6 |
Depreciation DepreciationCr | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| 1 | 1 | 1 | 3 | 5 | 1 | 2 | 6 | 5 | 2 | 5 | 10 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
|
Growth YoY PAT Growth YoY% | 147.1 | 28.2 | -29.8 | 6.7 | 280.9 | -1.1 | 121.7 | 82.2 | 12.9 | 71.1 | 27.7 | 18.4 |
| 1.9 | 1.1 | 0.9 | 2.6 | 7.4 | 1.0 | 1.5 | 3.8 | 5.3 | 1.2 | 1.6 | 3.4 |
| 0.1 | 0.1 | 0.8 | 0.3 | 0.4 | 0.1 | 0.2 | 0.5 | 0.4 | 0.1 | 0.2 | 0.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -29.2 | 43.9 | 1.7 | 30.6 | 2.9 | 24.7 | 16.1 | 5.1 | 9.7 | 28.5 | 23.8 |
| 161 | 112 | 165 | 156 | 210 | 225 | 278 | 330 | 344 | 377 | 478 | 597 |
Operating Profit Operating ProfitCr |
| 5.9 | 7.5 | 5.3 | 12.1 | 9.3 | 5.8 | 6.5 | 4.5 | 5.2 | 5.3 | 6.5 | 5.8 |
Other Income Other IncomeCr | 0 | 0 | 0 | 2 | 6 | 11 | 5 | 8 | 8 | 8 | 10 | 13 |
Interest Expense Interest ExpenseCr | 4 | 5 | 4 | 9 | 10 | 12 | 13 | 10 | 14 | 14 | 22 | 22 |
Depreciation DepreciationCr | 2 | 3 | 2 | 8 | 8 | 7 | 7 | 6 | 5 | 5 | 5 | 5 |
| 4 | 2 | 3 | 6 | 9 | 6 | 5 | 7 | 8 | 10 | 15 | 22 |
| 1 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 5 | 5 |
|
| | -37.9 | -7.0 | 134.0 | 80.7 | -29.4 | -19.8 | 35.2 | 22.7 | 17.3 | 22.1 | 73.2 |
| 1.8 | 1.6 | 1.0 | 2.3 | 3.2 | 2.2 | 1.4 | 1.7 | 1.9 | 2.1 | 2.0 | 2.8 |
| 10.0 | 6.2 | 0.1 | 0.3 | 0.6 | 0.4 | 0.3 | 0.5 | 0.6 | 0.7 | 0.8 | 1.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 3 | 4 | 4 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| 16 | 18 | 33 | 37 | 36 | 41 | 45 | 51 | 58 | 66 | 77 | 81 |
Current Liabilities Current LiabilitiesCr | 39 | 37 | 42 | 85 | 110 | 138 | 183 | 123 | 169 | 183 | 218 | 256 |
Non Current Liabilities Non Current LiabilitiesCr | 5 | 7 | 19 | 17 | 20 | 19 | 25 | 38 | 31 | 34 | 24 | 75 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 42 | 39 | 46 | 88 | 126 | 162 | 223 | 185 | 233 | 246 | 279 | 372 |
Non Current Assets Non Current AssetsCr | 21 | 26 | 52 | 55 | 52 | 49 | 43 | 40 | 37 | 50 | 52 | 52 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 28 | -1 | 7 | -17 | 14 | 16 | 7 | -5 | 24 | 25 | 35 |
Investing Cash Flow Investing Cash FlowCr | -12 | -8 | -29 | -11 | -4 | -2 | 0 | -2 | -2 | -10 | -3 |
Financing Cash Flow Financing Cash FlowCr | -5 | -2 | 23 | 29 | -12 | -13 | -7 | 2 | -22 | -11 | -36 |
|
Free Cash Flow Free Cash FlowCr | 23 | -4 | 5 | -28 | 10 | 13 | 6 | -7 | 22 | 14 | 31 |
| 918.5 | -55.4 | 369.5 | -418.5 | 185.2 | 303.2 | 160.1 | -79.9 | 338.5 | 297.2 | 342.6 |
CFO To EBITDA CFO To EBITDA% | 279.4 | -11.7 | 70.9 | -80.9 | 64.4 | 115.5 | 35.2 | -29.5 | 125.9 | 116.1 | 104.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 161 | 215 | 131 | 63 | 83 | 100 | 82 | 134 | 146 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 90.6 | 51.7 | 17.5 | 11.9 | 19.4 | 17.2 | 11.6 | 16.1 | 14.5 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.9 | 1.2 | 0.6 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 |
Price To Book Price To Book | 0.0 | 0.0 | 4.4 | 5.2 | 2.7 | 1.2 | 1.4 | 1.6 | 1.2 | 1.7 | 1.6 |
| 2.4 | 3.8 | 22.2 | 13.7 | 9.8 | 10.5 | 10.2 | 14.5 | 11.5 | 13.2 | 9.6 |
Profitability Ratios Profitability Ratios |
| 12.1 | 17.3 | 12.1 | 24.9 | 22.9 | 19.6 | 17.2 | 16.3 | 16.7 | 14.3 | 15.6 |
| 5.9 | 7.5 | 5.3 | 12.1 | 9.3 | 5.8 | 6.5 | 4.5 | 5.2 | 5.3 | 6.5 |
| 1.8 | 1.6 | 1.0 | 2.3 | 3.2 | 2.2 | 1.4 | 1.7 | 1.9 | 2.1 | 2.0 |
| 13.8 | 11.1 | 8.4 | 11.9 | 14.7 | 12.5 | 10.2 | 9.2 | 10.6 | 10.5 | 14.3 |
| 15.8 | 9.2 | 4.8 | 10.1 | 15.4 | 9.8 | 7.3 | 9.0 | 10.0 | 10.5 | 11.3 |
| 4.9 | 3.0 | 1.8 | 2.9 | 4.2 | 2.5 | 1.6 | 2.6 | 2.6 | 2.8 | 3.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Zeal Aqua Limited is a vertically integrated aquaculture company headquartered in Surat, Gujarat, established in 2009. It operates a **farm-to-fork supply chain**, managing all stages—from shrimp farming and hatchery support to processing and global export. The company specializes in high-quality **Tiger Prawn and White Shrimp (Vannamei)** production using sustainable, technology-driven practices. With operations across **300 hectares** in coastal Gujarat, Zeal Aqua serves over 15 international markets while strategically expanding into India’s domestic seafood sector.
---
### **Core Business Segments (FY 2023–24)**
1. **Shrimp Farming** – Primary operational focus, including owned and satellite farms.
2. **Shrimp Processing** – Value addition and export-ready packaging at its modern facility.
3. **Trading of Shrimp Feeds and Medicines** – Ancillary business supporting farmers.
---
### **Production & Infrastructure (as of Mar 2023)**
- **Annual Shrimp Production Capacity:** **2,000 MT** (up from 1,500 MT in 2015).
- **Farming Area:** 160 farms across 300 hectares (Surat and Bharuch), comprising HDPE-lined and earthen ponds.
- **Broodstock:** Uses 27th-generation SPF (Specific Pathogen Free) broodstock from top Indian hatcheries.
- **Processing Plant:**
- **Installed Capacity:** 5,850 MT per annum (MTPA).
- **Freezing Technologies:** IQF, plate freezing, blast freezing, and block freezing.
- **Cold Storage:** 2,200 MT capacity.
- **Proximity:** Farms located within 25 km of processing unit, ensuring **harvest-to-processing in under 2 hours** for superior freshness.
Half of the company’s land remains undeveloped, offering significant potential for **scaling up production** in the future.
---
### **Sustainability & Certifications**
- **Certifications:**
- **ASC (Aquaculture Stewardship Council)** – First in India with ASC-certified Black Tiger shrimp ponds; also ASC-certified Vannamei.
- **BRC Global Standard (Food Safety)**
- **HACCP**
- **Environmental Compliance:**
- Operates its own **Effluent Treatment Plant (ETP)**.
- Implements zero-antibiotic policy across all farms.
- Emphasizes biosecurity, traceability, and eco-friendly farming practices.
The company aligns with the **‘farm-to-fork’** trend, producing **organically cultivated, antibiotic-free shrimp** compliant with international standards.
---
### **Global Market Reach & Export Strategy**
- **Export Markets (as of Sep 2025):** Belgium, Denmark, France, Germany, Greece, Japan, South Korea, Busan (Korea), Netherlands, USA, Vietnam, Spain, Australia, and other EU nations.
- **Key Partnership:**
- Exclusive agreement with **Lenk Sea Foods (Germany)**, through which **~80% of production is currently exported**, primarily to the **EU market**.
- Strategic collaboration to expand **Black Tiger shrimp sales in Southern Europe**.
- **Government Recognition:**
- Upgraded to **‘3-Star Export House’** status (Sep 2025), qualifying for enhanced export incentives.
- **Export Infrastructure:**
- 10-member export team managing documentation, logistics, and compliance.
- Processing unit established in **Surat (2017)** with strategic focus on **EU markets**, differentiating from competitors targeting the USA and China.
**USFDA Approval:** Actively pursuing USFDA clearance to unlock the **US market**, improve plant utilization, and boost economies of scale.
---
### **Innovation & Operational Efficiency**
- **Nursery Project:** Successful implementation reduces the production cycle, enabling multiple harvests per year and higher output.
- **Satellite Farming Model (since Sep 2023):**
- Supports **small aquaculture farmers** by supplying feed, probiotics, auto feeders, and aeration systems.
- Provides training on **biosecurity, sustainability, food safety, traceability, and antibiotic management**.
- Ensures consistent supply of export-grade shrimp; satellite farms contribute up to **4,000 MTPA** potential.
- **Technology Use:** HDPE-lined ponds, in-house lab testing, automated feeding, and real-time water quality monitoring.
---
### **Branding & Market Expansion**
- **International Brands:** Markets shrimp under **‘Navik’ and ‘Patel’** in Japan.
- **Growth Strategy:**
- **Exports:** Participation in global trade exhibitions, virtual meetings, and expos.
- **Domestic Market:** Aggressive push via **digital marketing, direct sales, network marketing, and channel partnerships** to bring export-quality seafood to Indian consumers (strategic priority since FY 2023–24).
---
### **Industry Context & Challenges**
- **Market Opportunity:**
- Indian shrimp production led by **Andhra Pradesh (50%+ of national output)**, followed by Gujarat.
- Global shrimp market projected to grow at **5% CAGR**, driven by rising demand for healthy, protein-rich, and convenient seafood.
- Government support for **sustainable aquaculture** and value-added exports (e.g., ready-to-eat/cook products) via **MPEDA and SEAI**.
- **Challenges:**
- Volatile shrimp pricing impacting profitability.
- High setup and compliance costs limiting SME participation.
- Overreliance on Vannamei species; need for diversification.
- Middlemen control ~40% of the market, affecting traceability.
- Limited value-added processing capacity in India.
- Risk of disease outbreaks despite SPF seed availability.